Phlegm-dampness Obstruction Type Essential Hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with primary hypertension and identified as having phlegm-dampness stagnation syndrome according to (diaagnosis). 2. Patients with Grade 1 hypertension who did not achieve target levels after 12 weeks of lifestyle intervention and patients with Grade 2 hypertension. 3. Patients classified as low-risk, medium-risk, or high-risk based on risk stratification. 4. Patients aged 18 to 65 years, regardless of gender. 5. Patients who provided informed consent and voluntarily participated.
Exclusion criteria
Exclusion criteria: 1. Pseudohypertension/malignant hypertension and those with acute cerebrovascular disease, myocardial infarction, heart failure, or diabetic nephropathy; 2. Pregnant or breastfeeding women; 3. Skin ulceration/injury/inflammation/severe edema at the intervention site; 4. Currently participating in other clinical trials.1.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure;TCM Syndrome Score;Five lipid tests; | — |
Secondary
| Measure | Time frame |
|---|---|
| Homocysteine;Hamilton Anxiety Rating Scale;SF-36 Health Survey; | — |
Countries
China
Contacts
Hunan University of Traditional Chinese Medicine First Affiliated Hospital